Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02023905
Title Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

high grade glioma

Therapies

Temozolomide

Everolimus

Age Groups: adult
Covered Countries USA


No variant requirements are available.